Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J AudrainC Lerman

Abstract

To assess preferences for the content and process of genetic counseling and testing for breast-ovarian cancer susceptibility among women at high risk for breast cancer. Ninety-eight healthy women who had a family history of breast cancer in at least two first-degree relatives participated in a structured telephone survey that evaluated preferences for type of provider and the content and process of pretest education and posttest genetic counseling. Forty-two percent of women preferred that pretest education be delivered by a genetic counselor, while 22% preferred an oncologist. This preference was positively associated with a desire to discuss psychosocial issues during the session (P = .001). For posttest counseling, 38% of women preferred an oncologist, while 20% preferred a genetic counselor. However, women who desired supportive counseling during this session were significantly more likely to prefer a genetic counselor to an oncologist (P = .02). Fewer women wished to see a primary care physician or gynecologist for pretest education (11%) or posttest counseling (22%). With regard to the counseling process, 82% of women wished to self-refer for genetic counseling, but 63% desired advice and recommendations about whether to ...Continue Reading

Citations

Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L G BlumanE P Winer
Oct 20, 2000·Psycho-oncology·K FrancoE Tung
Jan 17, 2002·Zeitschrift für Psychosomatische Medizin und Psychotherapie·M Keller
Oct 9, 2002·Clinical Obstetrics and Gynecology·Thomas S Frank, Gregory C Critchfield
Oct 24, 2002·The American Journal of Nursing·Vanessa L Zimmerman
Jun 1, 2006·Familial Cancer·Carmel ApicellaJohn L Hopper
Dec 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Clara L GaffGeoffrey Lindeman
Aug 16, 2016·European Journal of Human Genetics : EJHG·Nicoline Hoogerbrugge, Marjolijn Cj Jongmans
Feb 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Jessica T LeeLillie Shockney
Mar 11, 2004·Journal of General Internal Medicine·Eugene C RichLouise Acheson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer CullenJeanne S Mandelblatt
Apr 3, 2001·Genetics in Medicine : Official Journal of the American College of Medical Genetics·J O CulverW Burke
Aug 16, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Almut W HelmesJürgen Bengel
Aug 25, 2011·Nature Reviews. Endocrinology·Steven G WaguespackGilbert J Cote
Jun 11, 2016·Archives of Gynecology and Obstetrics·Sabine EismannSarah Schott
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B N PeshkinC Isaacs
Apr 12, 2000·Cancer Control : Journal of the Moffitt Cancer Center·T S Frank
Sep 16, 2000·Breast Cancer Research and Treatment·P J Goodwin
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beth N PeshkinMarc D Schwartz
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hirohisa OsakaKosei Hirakawa
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wendy Y ChenFrederick P Li
Oct 20, 2001·Journal of Genetic Counseling·Patricia McCarthy VeachDianne M Bartels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Margaret L HollandKatia Noyes
© 2021 Meta ULC. All rights reserved